Pacific Biosciences Of California (PACB)
R&D Expense Growth
17.41%
Quarterly · Period ending:
PACB R&D Expense Growth
Latest reported17.41%period ending
Latest reported17.41%period ending
PACB Quarterly R&D Growth (QoQ) (0.00% → 17.41%)
Latest values, visible window
High-resolution chart · PNG
PACB r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 17.4113% | |
| -14.297% | |
| 0.1444% | |
| 1.4071% | |
| -22.4555% | |
| 5.7781% | |
| 7.6423% | |
| -33.6988% | |
| -11.4371% | |
| -2.4448% | |
| -6.2508% | |
| 2.9043% | |
| -5.6519% | |
| 14.8183% | |
| -9.4899% | |
| -6.467% | |
| -4.8907% | |
| 24.3353% | |
| 54.7768% | |
| 23.5426% | |
| 8.3609% | |
| 17.9225% | |
| 5.8177% | |
| 9.7069% | |
| -1.5738% | |
| 6.8451% | |
| -4.605% | |
| 0.3488% | |
| -3.7133% | |
| -4.7839% | |
| 13.2836% | |
| -8.3504% | |
| -3.9666% | |
| 4.3837% | |
| -1.3759% | |
| -6.1541% | |
| -0.5185% | |
| 4.4048% | |
| -7.0027% | |
| -0.2454% | |
| 7.0961% | |
| 10.907% | |
| -8.7242% | |
| 7.4387% | |
| 3.8666% | |
| 17.452% | |
| 5.4563% | |
| -5.967% | |
| 5.641% | |
| 5.7307% | |
| 6.8529% | |
| -10.8115% | |
| -2.5119% | |
| 2.8407% | |
| -7.7142% | |
| 12.0121% | |
| -6.6346% | |
| -2.7547% | |
| -37.9281% | |
| 2.3278% | |
| -18.9568% | |
| -9.1327% | |
| -19.259% | |
| 21.3832% | |
| 6.942% | |
| 2.6593% | |
| 16.7937% | |
| 0% |